Maria Lourdes Banaad Omiotek
Family Medicine · Chicago, ILNPI 1023085172
Payments from drug & device makers
Across 90 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$511
- Johnson & Johnson$252
- Pfizer$214
- Merck$101
- Dexcom, Inc.$95
- AstraZeneca$84
- plus $555 from 17 others
What the payments were for
- Food & beverage$1,807100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 27 | $511 |
| Johnson & Johnson | 8 | $252 |
| Pfizer | 9 | $214 |
| Merck | 7 | $101 |
| Dexcom, Inc. | 3 | $95 |
| AstraZeneca | 5 | $84 |
| Amgen(2 entities) | 4 | $76 |
| Abbott | 3 | $58 |
| Lilly USA, LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $53 |
| AbbVie | 3 | $45 |
| Bayer | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $28 |
| Redhill Biopharma Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Insulet Corporation | 1 | $21 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Mannkind Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$130
How this compares
$1,813 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 28 | $23,567 |
| Losartan Potassium | 76 | $773 |
| Amlodipine Besylate | 78 | $744 |
| Atorvastatin Calcium | 77 | $584 |
| Simvastatin | 53 | $512 |
| Metformin Hcl | 69 | $422 |
| Enalapril Maleate | 12 | $402 |
| Levothyroxine Sodium | 39 | $354 |
| Allopurinol | 26 | $289 |
| Rosuvastatin Calcium | 19 | $263 |
| Metoprolol Succinate | 13 | $257 |
| Pantoprazole Sodium | 23 | $244 |
| Metoprolol Tartrate | 35 | $183 |
| Alendronate Sodium | 31 | $168 |
| Gabapentin | 12 | $163 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $101 | $23,56728 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Chicago
- Bradley TorphyChicago$3M
- Frank PhillipsChicago$1.6M
- Ayoade AkereChicago$484K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
- Jacqueline OlivoChicago$165K
- Sameer PanjwaniChicago$136K
- Igor AltmanChicago$64K
- Juan RojasChicago$40K
- Mark SimonChicago$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.